This event has the main objective of advising how to manage cancer through transanal minimally invasive surgery (TAMIS). Dr. Antonio Caycedo Marulanda will discuss his experience and outcomes in performing TAMIS for the management of benign large rectal polyps and early malignant rectal cancers.

Dr. Caycedo's study is based on the first Canadian center to adopt the technique and includes indications such as a lesion diameter of less than 30% of the circumference and T1 with a benign lesion. However, contraindications include positive lymph nodes, distant metastasis, and ulcerated tumors.

The importance of magnetic resonance imaging (MRI) for the management of patients with rectal villous adenoma will also be discussed.

One crucial aspect that will be addressed is the surgical defect after transanal endoscopic microsurgery (TEM): open versus closed management. This is an important consideration for achieving optimal outcomes, minimizing complications, and promoting faster recovery.

Lastly, the NEO trial will also be discussed, evaluating the use of neoadjuvant chemotherapy and radiation therapy in combination with TAMIS for patients with locally advanced rectal cancer.

Faculty keyboard_arrow_down

Dr. Antonio Caycedo MD, MSc, FRCS Chief of Colorectal Surgery at Orlando Health, Medical Director for the National Accreditation Program for Rectal Cancer (NAPRC), Professor of Surgery at the University of Central Florida, Adjunct Associate Professor of Surgery at Queen’s University, Associate Clinical Researcher at the Health Sciences North Research Institute (HSNRI), Orlando, USA Colorectal Surgery

AIS Ambassador